Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone marrow transplantation: a review.

R E Hardy, E V Ikpeazu

    Journal of the National Medical Association
    |May 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Bone marrow transplantation improves leukemia treatment by applying immunologic principles. However, its use for benign blood disorders is currently controversial and not routinely recommended due to ethical concerns and potential complications.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Recognizing hypochondriasis in primary care.

    The Nurse practitioner·2001
    Same author

    Difficulty in reaching low-income women for screening mammography.

    Journal of health care for the poor and underserved·2000
    Same author

    Stages of change and the intake of dietary fat in African-American women: improving stage assignment using the Eating Styles Questionnaire.

    Journal of the American Dietetic Association·1999
    Same author

    Cryptococcal meningitis occurring at 19 months after cladribine therapy for hairy cell leukemia.

    European journal of haematology·1998
    Same author

    Cancer rate differentials between blacks and whites in three metropolitan areas: a 10-year comparison.

    Journal of the National Medical Association·1998
    Same author

    Dietary factors and cancers of breast, endometrium, and ovary: strategies for modifying fat intake in African American women.

    American journal of obstetrics and gynecology·1997
    Same journal

    Perioperative outcomes: Transforming healthcare.

    Journal of the National Medical Association·2026
    Same journal

    The intersection of infectious diseases and cardiovascular disease in Africa: A narrative review.

    Journal of the National Medical Association·2026
    Same journal

    Atrial fibrillation in chronic heart failure: prevalence and one-year outcome in the Ibadan chronic heart failure project.

    Journal of the National Medical Association·2026
    Same journal

    Corrigendum to ``Medical student perspectives of leadership development in community engagement'' [In Press].

    Journal of the National Medical Association·2026
    Same journal

    Ethno-racial trauma and well-being in medical education: A scoping review of U.S. physician trainees and medical students.

    Journal of the National Medical Association·2026
    Same journal

    Cuts to medicaid and the affordable care act: Negative consequences for the black community.

    Journal of the National Medical Association·2026
    See all related articles

    Area of Science:

    • Immunology
    • Hematology
    • Oncology

    Background:

    • Bone marrow transplantation (BMT) applies immunologic principles to treat bone marrow disorders.
    • Significant advancements in BMT outcomes have been observed over the last 15 years, particularly for leukemia treatment.

    Purpose of the Study:

    • To review the current applications and limitations of bone marrow transplantation.
    • To discuss the potential of autologous BMT for solid tumors and leukemias.
    • To address the controversial use of BMT for benign hematologic disorders.

    Main Methods:

    • Review of immunologic principles applied in BMT.
    • Analysis of treatment outcomes for neoplastic and benign hematologic disorders.
    • Discussion of complications associated with BMT.

    Related Experiment Videos

    Main Results:

    • BMT has shown marked improvement in treating acute and chronic leukemias.
    • Autologous BMT holds promise for leukemias and solid tumors, pending improved neoplastic cell removal.
    • Routine use of BMT for severe benign hematologic disorders like thalassemia and sickle cell anemia is not recommended due to ethical concerns and risks.

    Conclusions:

    • Bone marrow transplantation is a key immunologic therapy for hematologic malignancies.
    • Further research is needed to optimize autologous BMT for various cancers.
    • Current indications for BMT in benign hematologic conditions require careful ethical consideration and are not standard practice.